Valneva Spies Chance To Join Third Wave Of COVID-19 Vaccines

Boosted By UK Vaccine Taskforce Payments

 
• By Andrew McConaghie

The company is hoping for strong efficacy from its inactivated vaccine, boosted by two adjuvants

COVID-19 vaccination
Valneva believes the inactivated vaccine plus novel adjuvant can help it achieve a good safety and efficacy profile

More from Business

More from Scrip